Streetbeat News

Analyst Ratings

FMBH

Raymond James analyst Daniel Tamayo has maintained an Outperform rating on First Mid Bancshares (NASDAQ:FMBH) and increased the price target from $34 to $38.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:05 pm

LHX

Raymond James analyst Brian Gesuale has reaffirmed an Outperform rating on L3Harris Technologies (NYSE:LHX) and increased the price target from $220 to $235.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:04 pm

BOTZ

CVX

IBB

IYW

KRYS

MSFT

VTYX

XLE

XOM

Experts predict a resurgence in M&A activity in 2024 after a slump in 2023, with AI, biotech, and energy sectors expected to lead. Morgan Stanley's Tom Miles and Pitchbook's Tim Clarke attribute the 2023 downturn to market volatility and high interest rates, which particularly affected private equity firms. M&A volumes fell to $2.4 trillion in 2023 from $5.2 trillion in 2021. Microsoft's partnership with OpenAI, potential biotech acquisitions, and big oil deals like ExxonMobil's purchase of Pioneer Natural Resources and Chevron's acquisition of Hess Corp are highlighted. ETFs like IYW, BOTZ, IBB, and XLE, as well as the Russell 2000 index, could benefit from the anticipated M&A uptick.

Portfolio Pulse from Neil Dennis

January 29, 2024 | 2:03 pm

QCRH

Raymond James analyst Daniel Tamayo has maintained an Outperform rating on QCR Holdings (NASDAQ:QCRH) and increased the price target from $60 to $72.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:02 pm

WRK

WestRock (NYSE:WRK) has been analyzed by 4 financial analysts, maintaining an 'Indifferent' consensus with no change in ratings over the last 30 days. The average 12-month price target is $43.25, up from $41.00, with a high of $48.00 and a low of $40.00. Analysts from Wells Fargo, Truist Securities, and RBC Capital have adjusted their price targets, reflecting their response to WestRock's performance and market conditions. WestRock's financials show a decline in revenue growth, a strong net margin, and ROE, as well as a healthy debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 2:00 pm

EXP

Eagle Materials (NYSE:EXP) has received varied analyst ratings over the past quarter, with 3 bullish and 1 somewhat bullish ratings. The 12-month price targets have an average of $226.25, up 14.41% from the previous target. Analysts from Raymond James, Truist Securities, Goldman Sachs, and Stifel have all raised their price targets for EXP. The company's financial performance shows strong revenue growth, net margin, ROE, and ROA, but a higher debt-to-equity ratio than industry norms. Eagle Materials produces construction products and building materials for various industries, including oil and natural gas extraction.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 2:00 pm

SSB

SouthState (NYSE:SSB) received mixed analyst ratings with 1 bullish and 2 indifferent in the past three months. The average 12-month price target is $91.0, up from the previous $72.0, with a high estimate of $102.00 and a low of $78.00. The company, a bank holding company operating in the Southeastern US, has shown strong profitability with a net margin of 28.99% and ROE of 2.36%, but experienced a revenue decline of -1.65% over the last quarter.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 2:00 pm

Analysts have provided diverse ratings for Bloom Energy (NYSE:BE) with 11 recent assessments. The average 12-month price target is $17.73, down 8.8% from the previous average. Actions taken by analysts include lowering and raising price targets and ratings. Bloom Energy's financials show a revenue growth of 36.95%, a high net margin of -42.22%, and a debt-to-equity ratio of 2.97. The company's market position and future prospects are reflected in these analyst ratings and financial indicators.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 2:00 pm

TBBK

Raymond James analyst David Feaster has maintained an Outperform rating on Bancorp (NASDAQ:TBBK) and increased the price target from $42 to $50.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:00 pm

ADMQ

CATX

ETST

RVP

Insiders at Retractable Technologies, Perspective Therapeutics, ADM Endeavors, and Earth Science Tech have recently purchased shares of their respective companies, signaling confidence in their prospects. Retractable Technologies reported an operational loss for the first nine months of 2023, while Perspective Therapeutics received a Buy rating and price target from B. Riley Securities. ADM Endeavors' stock has risen significantly over the past month, and Earth Science Tech reported a net profit for its fiscal second quarter.

Portfolio Pulse from Avi Kapoor

January 29, 2024 | 1:53 pm